Before your Series A, your board was probably just you and your co-founder. Maybe a mentor or early angel sat in on meetings informally. Decisions happened over Slack, and nobody talked about “governance” because there was nothing to govern — you were just building.
After a Series A, that changes. Your lead investor will almost certainly negotiate a board seat. The shareholders’ agreement will specify how directors are appointed and removed, which decisions require board approval, and what the founder-directors can and cannot do without investor consent. Get this wrong and you can find yourself unable to make basic operational decisions without convening a formal board vote.
This guide covers how board composition typically works after a Series A in Australia, what the Corporations Act 2001 (Cth) requires, and the practical governance issues founders need to navigate.
The Typical Post-Series A Board
There is no single template, but most Australian startups land on one of two structures after a Series A:
Three-person board: Two founder seats and one investor nominee. This is common where the round is smaller (say, $3–5 million) and the lead investor is comfortable with founders retaining control. The founders hold a majority and can pass ordinary board resolutions without investor support.
Five-person board: Two founder seats, two investor seats (one for the Series A lead, one for an earlier seed investor or a second Series A participant), and one independent director. This is the more institutionalised structure, and it is increasingly standard for rounds above $5 million. The independent director is typically agreed between the founders and the lead investor.
In both cases, the structure is set out in the shareholders’ agreement — not in the company’s constitution. The constitution governs the mechanics of director appointment and removal under the replaceable rules, but the shareholders’ agreement overrides these in practice by creating binding contractual obligations about who gets to nominate directors and how many seats each party controls.
Investor Nominee Directors: What Founders Need to Know
When an investor takes a board seat, they typically appoint a “nominee director” — a partner or principal from the VC fund who represents the investor’s interests on the board. This is contractual, not statutory. The Corporations Act does not recognise a special category of “investor nominee director.” Once appointed, a nominee director has exactly the same legal obligations as every other director.
This is the single most important point founders and investors often misunderstand. An investor nominee is not on the board to represent the fund’s interests. They are on the board to act in the best interests of the company.
Directors’ Duties Apply Equally
Under sections 180 to 184 of the Corporations Act, every director — including investor nominees — must:
- Exercise care and diligence (section 180) to the standard of a reasonable person in that position.
- Act in good faith in the best interests of the company and for a proper purpose (section 181).
- Not improperly use their position to gain an advantage for themselves or someone else (section 182).
- Not improperly use information obtained through their role (section 183).
These are not aspirational guidelines. They are civil penalty provisions, with criminal sanctions under section 184 for dishonest breaches. An investor nominee who consistently votes in the fund’s interest rather than the company’s interest is breaching their duties — even if the shareholders’ agreement contemplated them representing the investor.
Conflicts of Interest
Investor nominees face inherent conflicts. Their fund holds shares in the company. Their fund may also hold shares in competitors. Their fund’s limited partners may have views about the company’s direction that differ from what is best for the company itself.
The Corporations Act addresses conflicts through section 191, which requires directors to disclose material personal interests in matters before the board. Where a conflict exists, the director may need to recuse themselves from the relevant discussion and vote. The shareholders’ agreement should include a protocol for managing these conflicts — specifying when disclosure is required, when recusal is appropriate, and how conflicted matters are handled procedurally.
Founders should pay attention to this during negotiation. A poorly drafted conflict protocol can leave you with a board member who participates in discussions about transactions that directly benefit their fund at the company’s expense.
Board Observer Rights
Not every investor gets a board seat. Seed investors, smaller participants in the Series A, and strategic investors often negotiate board observer rights instead. An observer can attend board meetings and receive board papers but cannot vote.
Observer rights are entirely contractual — they are not recognised under the Corporations Act. This means their scope, limitations, and termination conditions need to be spelled out in the shareholders’ agreement. Key issues to address include:
- Confidentiality: Observers receive sensitive commercial information. The agreement should bind them to confidentiality obligations equivalent to those imposed on directors.
- Exclusion rights: The board should retain the right to exclude observers from discussions involving conflicts of interest, litigation strategy, or matters where legal professional privilege might be waived by their presence.
- No fiduciary duties: Unlike directors, observers do not owe fiduciary duties to the company. This means they can — and will — share information with their fund and act on it in their capacity as investors. Founders should be aware of this asymmetry.
Reserve Matters and Investor Veto Rights
Board composition is only half the governance picture. The other half is reserve matters — decisions that require investor consent (at the board level or the shareholder level) before the company can act.
After a Series A, the shareholders’ agreement will typically include a list of reserve matters that cannot be approved by the board alone. Common examples include:
- Issuing new shares or granting options beyond an approved ESOP pool
- Taking on debt above a specified threshold
- Entering into transactions above a certain dollar value
- Changing the company’s constitution
- Appointing or removing the CEO
- Approving the annual budget
- Selling the company or substantially all of its assets
- Winding up the company or entering voluntary administration
For founders, the critical question is not whether reserve matters exist — they almost always will — but how broad they are and at what thresholds they bite. A reserve matter that requires investor consent for any expenditure above $50,000 is very different from one that only applies above $500,000. The tighter the thresholds, the more operational freedom you lose.
Negotiate reserve matters carefully. Push for thresholds that reflect the company’s stage and burn rate. A Series A company spending $200,000 per month should not need investor sign-off on routine supplier contracts.
The Independent Director
In a five-person board structure, the independent director occupies a pivotal role. They are not aligned with the founders or the investors, and in a deadlocked board (two founder votes versus two investor votes), the independent casts the deciding vote.
Choosing the right independent matters enormously. Both founders and investors typically have approval rights over the independent director appointment, and the shareholders’ agreement should specify the selection process. In practice, the lead investor often proposes candidates and the founders have a veto — or vice versa.
An effective independent director for an early-stage company should bring relevant industry expertise, board experience (ideally with other venture-backed companies), and genuine independence from both the investor and the founder group. They should not be a partner at the lead VC fund. They should not be the founder’s university friend. They should be someone both sides trust to make principled decisions when interests diverge.
Under the Corporations Act, there is no statutory requirement for proprietary companies to appoint independent directors. This is a contractual governance choice, driven by the shareholders’ agreement. But it is a choice that can define the quality of your board’s decision-making for years.
Practical Governance After Series A
Beyond the legal framework, there are practical governance habits that founders should adopt once the board expands:
Run proper board meetings. Set a regular cadence — monthly or bi-monthly. Circulate board papers at least three business days in advance. Include a CEO report, financial statements, KPI dashboards, and an agenda with clearly identified decision items. Investor directors expect this, and it makes the board more effective.
Keep minutes. Board minutes are a legal record of decisions made and the reasoning behind them. Under section 251A of the Corporations Act, a company must keep minutes of all board meetings. Good minutes protect directors by evidencing that they considered relevant information and exercised their judgment. Bad minutes — or no minutes — create problems in disputes and due diligence.
Manage information flow. The shareholders’ agreement will include information rights — typically monthly or quarterly financial reports, annual budgets, and prompt notification of material events. Treat these as a minimum, not a maximum. Proactive communication with your board builds trust and reduces the chance of surprises that erode investor confidence.
Know your residency requirements. Under section 201A of the Corporations Act, a proprietary company must have at least one director who ordinarily resides in Australia. If your co-founder is based overseas and the investor nominee is in Singapore, you need to ensure the residency requirement is met. This is easily overlooked in the excitement of closing a round.
The Bottom Line
Your board after a Series A is not just a formality — it is a governance structure with real legal consequences. Every director, including investor nominees, owes duties to the company under the Corporations Act. Reserve matters constrain what you can do without investor consent. The composition of the board determines how decisions get made when founders and investors disagree.
Get the structure right during the Series A negotiation, when you have leverage. Understand the duties that apply to every person sitting around the table. And invest in the governance habits — proper meetings, good minutes, clear communication — that make the board a strategic asset rather than a bureaucratic obligation.
